Clobazam 10 Adco, Clobazam 20 Adco 10 mg, 20 mg, Tablets
PDF Leaflet Revision Date: 21 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of anxiety in neurotic patients and pre-operative medication.
Dosage (summary)
10-30 mg daily; elderly and children: halve the dose.
Special Populations
- Elderly
- Paediatric Population
- CYP2C19 poor metabolizers
Pregnancy & Breastfeeding
Not recommended in the first trimester; contraindicated in breastfeeding.
Key Drug Interactions
- Alcohol
- Opioids
- CNS depressants
Contraindications
- Hypersensitivity to benzodiazepines
- History of drug/alcohol dependence
- Myasthenia gravis
- Severe respiratory insufficiency
- Severe hepatic insufficiency
- First trimester of pregnancy
- Breastfeeding
Common side effects
- Somnolence
- Dizziness
- Irritability
- Dry mouth
- Fatigue
Counselling Points
- Avoid alcohol during treatment.
- May impair ability to drive or operate machinery.
- Treatment duration should be limited to 8-12 weeks.
Serious warnings
- Risk of dependence
- Amnesia
- Serious skin reactions (SJS/TEN)
- Respiratory depression
Important Disclaimer
The Clobazam 10 Adco, Clobazam 20 Adco 10 mg, 20 mg, Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
